0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Diagnosis and Treatment |

Theophylline Reassessed

MARIA BUKOWSKYJ, M.D.; KANJI NAKATSU, Ph.D.; and PETER W. MUNT, M.D.
[+] Article and Author Information

▸Requests for reprints should be addressed to Maria Bukowskyj, M.D.; Division of Respiratory Medicine, Department of Medicine, Queen's University; Kingston, ON K7L 3N6, Canada.


Kingston, Ontario, Canada


© 1984 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1984;101(1):63-73. doi:10.7326/0003-4819-101-1-63
Text Size: A A A

Advances have recently been made in understanding the pharmacokinetics of theophylline. To correlate the new knowledge of theophylline pharmacokinetics with the drug's current status in therapy, we have critically reviewed the relevant investigations of the last 5 years. We consider data on its presumed mechanisms of action, factors affecting its clearance, its use in pregnancy, treatment of overdoses, and important drug interactions. Theophylline clearance is decreased by concomitant use of erythromycin, cimetidine, high-dose allopurinol, oral contraceptives, and caffeine. Clearance is increased by concomitant use of phenobarbital and phenytoin. Newly discovered actions of theophylline include dose-dependent improvement of diaphragmatic contractility, augmentation of ventilatory response to hypoxia, and sleep disturbances (especially with high-dose treatments). Points clinically relevant to the daily use of theophylline derivatives and the importance of sustained-release preparations are discussed. Theophylline continues to play a major role in therapy for reactive airways disease.

Topics

theophylline

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Solid-state NMR studies of theophylline co-crystals with dicarboxylic acids. J Pharm Biomed Anal Published online Aug 7, 2014.;
[Prevention of acute exacerbation of chronic obstructive pulmonary disease.] Zhong Nan Da Xue Xue Bao Yi Xue Ban 2014;39(8):861-867.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)